1. Hypoxia-Responsive Stereocomplex Polymeric Micelles with Improved Drug Loading Inhibit Breast Cancer Metastasis in an Orthotopic Murine Model
- Author
-
Lu, Min, Huang, Xu, Cai, Xiaohui, Sun, Jiajia, Liu, Xuemeng, Weng, Lingyan, Zhu, Li, Luo, Qianqian, and Chen, Zhongping
- Subjects
Engineering ,Chemical Sciences ,Physical Sciences ,Orphan Drug ,Cancer ,Breast Cancer ,Rare Diseases ,5.1 Pharmaceuticals ,Development of treatments and therapeutic interventions ,Animals ,Breast Neoplasms ,Cell Line ,Tumor ,Disease Models ,Animal ,Drug Carriers ,Drug Delivery Systems ,Female ,Humans ,Hypoxia ,Melanoma ,Mice ,Micelles ,Polyesters ,Polyethylene Glycols ,Polymers ,Skin Neoplasms ,Melanoma ,Cutaneous Malignant ,breast cancer ,drug delivery ,hypoxia-responsiveness ,polymeric micelles ,stereocomplex ,tumor metastasis ,Nanoscience & Nanotechnology ,Chemical sciences ,Physical sciences - Abstract
Tumor metastasis is a leading cause of breast cancer-related death. Taxane-loaded polymeric formulations, such as Genexol PM and Nanoxel M using poly(ethylene glycol)-poly(d,l-lactide) (PEG-PLA) micelles as drug carriers, have been approved for the treatment of metastatic breast cancer. Unfortunately, the physical instability of PEG-PLA micelles, leading to poor drug loading, premature drug leakage, and consequently limited drug delivery to tumors, largely hinders their therapeutic outcome. Inspired by the enantiomeric nature of PLA, this work developed stereocomplex PEG-PLA micelles through stereoselective interactions of enantiomeric PLA, which are further incorporated with a hypoxia-responsive moiety used as a hypoxia-cleavable linker of PEG and PLA, to maximize therapeutic outcomes. The results showed that the obtained micelles had high structural stability, showing improved drug loading for effective drug delivery to tumors as well as other tissues. Especially, they were capable of sensitively responding to the hypoxic tumor environment for drug release, reversing hypoxia-induced drug resistance and hypoxia-promoted cell migration for enhanced bioavailability under hypoxia. In vivo results further showed that the micelles, especially at a high dose, inhibited the growth of the primary tumor and improved tumor pathological conditions, consequently remarkably inhibiting its metastasis to the lungs and liver, while not causing any systemic toxicity. Hypoxia-responsive stereocomplex micelles thus emerge as a reliable drug delivery system to treat breast cancer metastasis.
- Published
- 2022